Comments
Loading...

International Stem Cell Analyst Ratings

ISCOOTCQB
Logo brought to you by Benzinga Data
$0.1100
At close: May 21, 3:02 PM EDT

International Stem Cell Analyst Ratings and Price Targets | OTC:ISCO | Benzinga

International Stem Cell Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for International Stem Cell Corp from these most-recent analyst ratings.

Analyst Ratings for International Stem Cell

Buy NowGet Alert
No data available to display

FAQ

Q

What is the target price for International Stem Cell (ISCO) stock?

A

There is no price target for International Stem Cell

Q

What is the most recent analyst rating for International Stem Cell (ISCO)?

A

There is no analyst for International Stem Cell

Q

When was the last upgrade for International Stem Cell (ISCO)?

A

There is no last upgrade for International Stem Cell

Q

When was the last downgrade for International Stem Cell (ISCO)?

A

There is no last downgrade for International Stem Cell.

Q

When is the next analyst rating going to be posted or updated for International Stem Cell (ISCO)?

A

There is no next analyst rating for International Stem Cell.

Q

Is the Analyst Rating International Stem Cell (ISCO) correct?

A

There is no next analyst rating for International Stem Cell.

Browse analyst ratings and price targets on all stocks.